Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  128,950 results for ""Multiple myeloma""

Your Filters

Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Smouldering multiple myeloma: To seek or not to seek? To treat or not to treat. That is the question.

  • Authors : Vaxman I; Institute of Haematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikvah, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/diagnosis ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/therapy ; Monoclonal Gammopathy of Undetermined Significance*/Monoclonal Gammopathy of Undetermined Significance*/Monoclonal Gammopathy of Undetermined Significance*/diagnosis

  • Source: British journal of haematology [Br J Haematol] 2024 Apr; Vol. 204 (4), pp. 1141-1142. Date of Electronic Publication: 2024 Mar 01.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Periodical

Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper.

  • Authors : Hughes D; UCL Cancer Institute, University College London, London, UK.; Yong K

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/diagnosis ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/therapy ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/pathology

  • Source: British journal of haematology [Br J Haematol] 2024 Apr; Vol. 204 (4), pp. 1193-1206. Date of Electronic Publication: 2024 Feb 23.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Molecular Pathogenesis of Multiple Myeloma: Clinical Implications.

  • Authors : Maura F; University of Miami, 1120 Northwest 14th Street, Miami, FL 33136, USA. Electronic address: .; Bergsagel PL

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/genetics ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/therapy ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/pathology

  • Source: Hematology/oncology clinics of North America [Hematol Oncol Clin North Am] 2024 Apr; Vol. 38 (2), pp. 267-279. Date of Electronic Publication: 2024 Jan 09.Publisher: Elsevier Health Science Country of Publication: United States NLM ID: 8709473 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Chimeric Antigen Receptor T Cells in the Treatment of Multiple Myeloma.

  • Authors : Hasanali ZS; Division of Hematology/Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, 3400 Civic Center Boulevard, 12th Floor South Tower, Philadelphia, PA 19104, USA.; Razzo B

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/therapy ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/pathology ; Receptors, Chimeric Antigen*/Receptors, Chimeric Antigen*/Receptors, Chimeric Antigen*/genetics

  • Source: Hematology/oncology clinics of North America [Hematol Oncol Clin North Am] 2024 Apr; Vol. 38 (2), pp. 383-406. Date of Electronic Publication: 2023 Dec 28.Publisher: Elsevier Health Science Country of Publication: United States NLM ID: 8709473 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Use of venetoclax in t(11;14) positive relapsed/refractory multiple myeloma: A systematic review.

  • Authors : Khan WJ; Demonstrator (Teaching Faculty) Pharmacology and Therapeutics, Northwest School of Medicine, Peshawar, Pakistan.; Ali M

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/genetics ; Bridged Bicyclo Compounds, Heterocyclic*/Bridged Bicyclo Compounds, Heterocyclic*/Bridged Bicyclo Compounds, Heterocyclic*/therapeutic use

  • Source: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2024 Apr; Vol. 30 (3), pp. 552-561. Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Treatment with low-dose, single-agent belantamab mafodotin is safe and provides long-term responses in heavily pretreated multiple myeloma patients.

  • Authors : Avivi I; Department of Haematology, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/diagnosis ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy ; Antibodies, Monoclonal, Humanized*

  • Source: European journal of haematology [Eur J Haematol] 2024 Mar; Vol. 112 (3), pp. 367-370. Date of Electronic Publication: 2023 Oct 26.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

Record details

Read More Add to Saved list
×
Academic Journal

Enhancing multiple myeloma staging: a novel cell death risk model approach.

  • Authors : Deng Z; Department of Hematology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China.; Institute of Hematology, Central South University, Changsha, Hunan, People's Republic of China.

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/pathology ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/genetics ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/mortality

  • Source: Clinical and experimental medicine [Clin Exp Med] 2024 May 08; Vol. 24 (1), pp. 95. Date of Electronic Publication: 2024 May 08.Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

KIF22 promotes multiple myeloma progression by regulating the CDC25C/CDK1/cyclinB1 pathway.

  • Authors : Zhai M; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.; Xi'an Key Laboratory of Hematological Diseases, Xi'an, China.

Subjects: Kinesins*/Kinesins*/Kinesins*/metabolism ; Kinesins*/Kinesins*/Kinesins*/genetics ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/pathology

  • Source: Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 May 07; Vol. 150 (5), pp. 239. Date of Electronic Publication: 2024 May 07.Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 7902060 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1335

Record details

Read More Add to Saved list
×
Academic Journal

Research strategies of small molecules as chemotherapeutics to overcome multiple myeloma resistance.

  • Authors : Yang J; National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine, 138 Xianlin Road, Nanjing, Jiangsu, 210023, China.; Yu YC

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/pathology ; Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/drug effects

  • Source: European journal of medicinal chemistry [Eur J Med Chem] 2024 May 05; Vol. 271, pp. 116435. Date of Electronic Publication: 2024 Apr 20.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

An Assessment of the Effectiveness and Safety of Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma Patients with Relapsed or Refractory Disease: A Systematic Review and Meta-Analysis.

  • Authors : Pereira R; Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal.; Bergantim R

Subjects: Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/therapy ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/immunology ; Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/Immunotherapy, Adoptive*/adverse effects

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 May 03; Vol. 25 (9). Date of Electronic Publication: 2024 May 03.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

Read More Add to Saved list
×
  • 1-10 of  128,950 results for ""Multiple myeloma""